We’re Gonna Need a Bigger Boat
By KIM BELLARD My friends, we are like explorers of yore standing at the edge…
We’re Gonna Need a Bigger Boat
By KIM BELLARD My friends, we are like explorers of yore standing at the edge of a known continent, looking out at the vast ocean in hopes of finding new, unspoiled, better lands across it. True, we may have despoiled the continent behind us, but certainly things will be better in the new lands. In…
Is Your AI-Driven Healthcare Startup Ready for New Investment? Apply to INVEST Digital Health Pitch Perfect Today.
We’re getting close to the July 19 deadline for submissions. Don’t miss this opportunity to pitch your company to a team of investors at INVEST Digital Health in Dallas on September 18! The post Is Your AI-Driven Healthcare Startup Ready for New Investment? Apply to INVEST Digital Health Pitch Perfect Today. appeared first on MedCity…
Media Availability: What the Budget Reconciliation Law Could Mean for Health Coverage, Affordability, and the States
DATE: July 9, 2025 Now that President Trump has signed the megabill, KFF will hosted a virtual media availability for journalists on Wednesday, July 9 to answer questions about health care provisions in the law and their implications for health coverage, affordability, and state budgets, as well as potential political considerations for future elections. KFF’s…More
MedCity Pivot Podcast: Why Blood Pressure Monitoring Is Due for A New Era
[Sponsored] CoraVie Medical CEO Aimee Garza and Dr. Michael Bloch, a hypertension specialist and clinical advisor for the startup, talk about why the healthcare industry needs a better approach to blood pressure monitoring. CoraVie is developing an implantable device that measures patients’ blood pressure, operating in a similar way to continuous glucose monitors. Watch or…
Merck Breathes Life Into Its Respiratory Prospects With $10B Deal to Buy Verona Pharma
Verona Pharma bring to Merck the inhaled drug Ohtuvayre, which is FDA approved as a treatment for chronic obstructive pulmonary disease. While Ohtuvayre is projected to become a blockbuster product in COPD alone, its potential extends to other respiratory disorders as well. The post Merck Breathes Life Into Its Respiratory Prospects With $10B Deal to…
Mandatory by 2026: 5 Ways to Prepare for CMS’ TEAM Payment Model
For hospitals and health systems, the challenge is steep, but so is the opportunity. TEAM offers a framework to deliver more coordinated, cost-effective, and patient-focused care. Those who prepare now will be far better positioned to thrive in a value-based future. The post Mandatory by 2026: 5 Ways to Prepare for CMS’ TEAM Payment Model…
Beyond the Prescription: Supporting Long-Term Metabolic Health After GLP-1s
GLP-1s are a breakthrough, but they are not the end of the story. To ensure lasting success, we must pair pharmacological interventions with behavioral support, personalized data, and continuous guidance. The post Beyond the Prescription: Supporting Long-Term Metabolic Health After GLP-1s appeared first on MedCity News.
The Human Algorithm: What AI Can’t Replace in Pharma Engagement
[Sponsored] At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch. The post The Human Algorithm: What AI Can’t Replace in Pharma Engagement appeared first on MedCity News.
An Arm and a Leg: The Prescription Drug Playbook, Part II
In response to the high price of prescription drugs, “An Arm and a Leg” asked listeners to share their strategies for getting the medicine they need at prices they can manage. Host Dan Weissmann and producers Emily Pisacreta and Claire Davenport share tips from a retired hospital manager who now helps seniors find the right…
World’s Premier Cancer Institute Faces Crippling Cuts and Chaos
The Trump administration’s broadsides against scientific research have caused unprecedented upheaval at the National Cancer Institute, the storied federal government research hub that has spearheaded advances against the disease for decades. NCI, which has long benefited from enthusiastic bipartisan support, now faces an exodus of clinicians, scientists, and other staffers — some fired, others leaving…
